View article

In 1996, the Erectile Dysfunction Clinical Guideline Panel published the Report on the Treatment of Organic Erectile

Dysfunction (the 1996 Report), an evidence-based guideline for the diagnosis and treatment of erectile dysfunction (ED). 1 Since that time, impotence, more precisely termed “erectile dysfunction,” has received increasing attention because of the availability of new treatments approved by the US Food and Drug Administration (FDA). In addition, the overall quality of clinical research and the methods of measuring outcomes have improved substantially. The 1996 analysis was based mainly on the outcomes of clinical series. The randomized, controlled trial has now become the norm. An Erectile Dysfunction Guideline Update Panel (the Panel) was appointed by the American Urological Association (AUA) Practice Guidelines Committee in the year 2000 to update the existing document. Using a …